• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

修订版行为与症状识别量表(BASIS-R):信度与效度

The Revised Behavior and Symptom Identification Scale (BASIS-R): reliability and validity.

作者信息

Eisen Susan V, Normand Sharon-Lise, Belanger Albert J, Spiro Avron, Esch David

机构信息

Center for Health Quality Outcomes and Economics Research, Edith Nourse Rogers Memorial Veterans Hospital, Bedford, Massachusetts, USA.

出版信息

Med Care. 2004 Dec;42(12):1230-41. doi: 10.1097/00005650-200412000-00010.

DOI:10.1097/00005650-200412000-00010
PMID:15550803
Abstract

BACKGROUND

To assess outcomes of health services, providers need brief, responsive, reliable, and valid measures that can be implemented in clinical settings with minimal cost and burden. The Behavior and Symptom Identification Scale (BASIS-32) is a self-report measure developed in 1984 to assess mental health treatment outcomes. During the past 3 years, multiple methods were used to revise the instrument to improve reliability, validity, and applicability to diverse groups of mental health service recipients.

OBJECTIVE

The objective of this study was to field test the revised instrument, make further changes based on analysis of the field test data, and assess reliability and validity of the final version (BASIS-24).

METHODS

A field test was implemented at 27 treatment sites across the United States. A total of 2656 inpatients and 3222 outpatients participated. Factor analytic methods, classic test theory, and item response theory modeling were used to select the most discriminating, nonredundant items for inclusion in the final version of the instrument and to assess its reliability and validity. Item response theory modeling was used to score the instrument.

RESULTS

The final instrument includes 24 items assessing 6 domains: depression/ functioning, interpersonal relationships, self-harm, emotional lability, psychosis, and substance abuse. Test-retest and internal consistency reliability were acceptable. Tests of construct and discriminant validity supported the instrument's ability to discriminate groups expected to differ in mental health status, and its correlation with other measures of mental health.

CONCLUSIONS

Analyses of the BASIS-24 supported its reliability and validity for assessing mental health status from the patient's perspective.

摘要

背景

为评估卫生服务的效果,提供者需要简短、灵敏、可靠且有效的测量方法,这些方法应能在临床环境中以最小的成本和负担实施。行为与症状识别量表(BASIS - 32)是1984年开发的一种自评量表,用于评估心理健康治疗效果。在过去3年中,采用了多种方法对该工具进行修订,以提高其可靠性、有效性以及对不同心理健康服务接受者群体的适用性。

目的

本研究的目的是对修订后的工具进行现场测试,根据现场测试数据分析结果进一步修改,并评估最终版本(BASIS - 24)的可靠性和有效性。

方法

在美国27个治疗地点进行了现场测试。共有2656名住院患者和3222名门诊患者参与。采用因素分析方法、经典测试理论和项目反应理论模型来选择最具区分性、非冗余的项目纳入工具的最终版本,并评估其可靠性和有效性。使用项目反应理论模型对该工具进行评分。

结果

最终工具包括24个项目,评估6个领域:抑郁/功能、人际关系、自我伤害、情绪不稳定、精神病和药物滥用。重测信度和内部一致性信度均可接受。结构效度和区分效度测试支持该工具区分预期心理健康状况不同群体的能力,以及它与其他心理健康测量方法的相关性。

结论

对BASIS - 24的分析支持其从患者角度评估心理健康状况的可靠性和有效性。

相似文献

1
The Revised Behavior and Symptom Identification Scale (BASIS-R): reliability and validity.修订版行为与症状识别量表(BASIS-R):信度与效度
Med Care. 2004 Dec;42(12):1230-41. doi: 10.1097/00005650-200412000-00010.
2
Development of a social inclusion index to capture subjective and objective life domains (Phase II): psychometric development study.发展一个社会包容指数来捕捉主观和客观的生活领域(第二阶段):心理测量发展研究。
Health Technol Assess. 2012;16(1):iii-vii, ix-xii, -1-241. doi: 10.3310/hta16010.
3
Reliability and validity of a brief patient-report instrument for psychiatric outcome evaluation.一种用于精神科结局评估的简短患者报告工具的信度和效度。
Hosp Community Psychiatry. 1994 Mar;45(3):242-7. doi: 10.1176/ps.45.3.242.
4
The reliability, validity, and preliminary responsiveness of the Eye Allergy Patient Impact Questionnaire (EAPIQ).眼部过敏患者影响问卷(EAPIQ)的信度、效度及初步反应性
Health Qual Life Outcomes. 2005 Oct 31;3:67. doi: 10.1186/1477-7525-3-67.
5
Assessing recovery of people with serious mental illness: development of a new scale.评估严重精神疾病患者的康复情况:新量表的制定。
Psychiatr Serv. 2012 Jan;63(1):48-53. doi: 10.1176/appi.ps.201100109.
6
SEQUenCE: a service user-centred quality of care instrument for mental health services.SEQUenCE:一种以服务使用者为中心的心理健康服务护理质量工具。
Int J Qual Health Care. 2015 Aug;27(4):284-90. doi: 10.1093/intqhc/mzv043. Epub 2015 Jun 16.
7
Psychometric properties of the Japanese version of the Recovery Attitudes Questionnaire (RAQ) among mental health providers: a questionnaire survey.心理健康服务提供者中《康复态度问卷》(RAQ)日语版的心理测量学特性:一项问卷调查
BMC Psychiatry. 2016 Feb 16;16:32. doi: 10.1186/s12888-016-0740-x.
8
Translation and cultural adaptation of a mental health outcome measure: the BASIS-R(c).一种心理健康结果测量工具的翻译与文化调适:基础需求筛查量表修订版(BASIS-R(c))
Cult Med Psychiatry. 2007 Mar;31(1):25-49. doi: 10.1007/s11013-006-9043-x.
9
The reliability, validity, and applicability of an English language version of the Mini-ICF-APP.《Mini-ICF-APP 英文版的信度、效度和适用性》
Soc Psychiatry Psychiatr Epidemiol. 2013 Aug;48(8):1347-54. doi: 10.1007/s00127-012-0604-8. Epub 2012 Oct 19.
10
Reliability and validity of the Japanese version of the Recovery Assessment Scale (RAS) for people with chronic mental illness: scale development.慢性精神疾病患者康复评估量表(RAS)的日语版的信度和效度:量表编制。
Int J Nurs Stud. 2010 Mar;47(3):314-22. doi: 10.1016/j.ijnurstu.2009.07.006. Epub 2009 Aug 12.

引用本文的文献

1
Intervention for Justice-Involved Homeless Veterans With Co-Occurring Substance Use and Mental Health Disorders: Protocol for a Randomized Controlled Hybrid Effectiveness-Implementation Trial.针对同时患有物质使用障碍和精神健康障碍的涉司法无家可归退伍军人的干预措施:一项随机对照混合有效性-实施试验方案
JMIR Res Protoc. 2025 Jul 18;14:e70750. doi: 10.2196/70750.
2
Characteristics and outcomes of individuals screening positive for borderline personality disorder on an adult inpatient psychiatry unit: a cross-sectional study.成人住院精神科病房中边缘型人格障碍筛查呈阳性个体的特征与结局:一项横断面研究
BMC Psychiatry. 2025 May 5;25(1):452. doi: 10.1186/s12888-025-06928-8.
3
Prediction of individual treatment allocation between electroconvulsive therapy or ketamine using the Personalized Advantage Index.
使用个性化优势指数预测电休克治疗或氯胺酮之间的个体治疗分配。
NPJ Digit Med. 2025 Feb 27;8(1):127. doi: 10.1038/s41746-025-01523-3.
4
Protocol of a randomized controlled trial examining psychosocial enhancement and standard medication treatment for co-occurring opioid use and mental health disorders: A half fractional factorial randomized controlled trial.一项随机对照试验方案,旨在研究针对共病阿片类药物使用和精神健康障碍的心理社会增强和标准药物治疗:半析因随机对照试验。
Contemp Clin Trials. 2024 Oct;145:107668. doi: 10.1016/j.cct.2024.107668. Epub 2024 Aug 18.
5
Variation in benefit among patients with serious mental illness who receive integrated psychiatric and primary care.接受精神科和初级保健综合治疗的严重精神疾病患者的获益存在差异。
PLoS One. 2024 May 23;19(5):e0304312. doi: 10.1371/journal.pone.0304312. eCollection 2024.
6
The Characteristics of People with Serious Mental Illness Who are at High Risk for Hospitalization or Death.具有高住院或死亡风险的严重精神疾病患者的特征。
Community Ment Health J. 2024 Oct;60(7):1243-1246. doi: 10.1007/s10597-024-01281-8. Epub 2024 Apr 23.
7
Risks for re-hospitalization of persons with severe mental illness living in rehabilitation care settings.康复照料环境中患有严重精神疾病者再次住院的风险。
Isr J Health Policy Res. 2024 Apr 3;13(1):18. doi: 10.1186/s13584-024-00605-z.
8
Gender, Race/Ethnicity, and Patient-Therapist Matching on Gender and Race/Ethnicity: Predictors/Moderators of the Effectiveness of Trust/Respect Feedback.性别、种族/民族以及性别和种族/民族方面的患者与治疗师匹配度:信任/尊重反馈效果的预测因素/调节因素
Adm Policy Ment Health. 2025 Jan;52(1):59-73. doi: 10.1007/s10488-023-01335-1. Epub 2024 Jan 4.
9
Individual Prediction of Optimal Treatment Allocation Between Electroconvulsive Therapy or Ketamine using the Personalized Advantage Index.使用个性化优势指数对电休克治疗或氯胺酮之间的最佳治疗分配进行个体预测。
Res Sq. 2023 Nov 30:rs.3.rs-3682009. doi: 10.21203/rs.3.rs-3682009/v1.
10
A Seeking Safety Mobile App for Recovery from PTSD and Substance Use Disorder: Results of a Randomized Controlled Trial.一款用于创伤后应激障碍和物质使用障碍康复的“寻求安全”移动应用程序:一项随机对照试验的结果。
Subst Use Misuse. 2024;59(3):459-466. doi: 10.1080/10826084.2023.2280540. Epub 2024 Jan 25.